Subscribe to Newsletter

Content by Phoebe Harkin:

 Subspecialties Retina

Under the Lid

| Phoebe Harkin

Bringing clarity to the mechanisms behind AMD
Subspecialties Cornea / Ocular Surface

Root of the Problem

| Phoebe Harkin

Researchers uncover potential drug target in Sjögren’s syndrome

Subspecialties Health Economics and Policy

#NotOneMoreEye

| Phoebe Harkin

“Using your voice shouldn’t mean losing your sight” – ophthalmologists condemn the use of rubber bullets in the wake of George Floyd’s killing
Business & Profession Professional Development

A Woman's Work

| Phoebe Harkin

Isn't it time we recognize ophthalmology’s most influential women?
Business & Profession Business and Innovation

Business in Brief

| Phoebe Harkin

The latest industry news, appointments, mergers, and acquisitions – in 50 words or less

Subspecialties Comprehensive

Bulge, Begone

| Phoebe Harkin

An end to thyroid-related eye bulging?
Subspecialties Comprehensive

Strategy – and Humanity

| Phoebe Harkin

Sitting Down With… Jeanne Hecht, CEO of Ora
Business & Profession Business and Innovation

Business in Brief

| Phoebe Harkin

The industry’s contributions to the global fight against COVID-19

Subspecialties Retina

The H Factor

| Phoebe Harkin

Researchers uncover a new connection between elevated FHR-4 levels and AMD
Subspecialties Comprehensive

Liquid Gold

| Phoebe Harkin

CHLA researchers uncover a breakthrough biopsy method for retinoblastoma

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

July Issue of The Ophthalmologist
Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.